Relationship between lipophilicity of C6-10 hydrocarbon solvents and their ROS-inducing potency in rat cerebellar granule cells

NeuroToxicology

Volumn 23, Issue 6, 2002, Pages 701-709

  Dreiem, Anne ^a   Myhre, O ^a,b   Fonnum, F ^a  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b STATOIL   (Norway)

Author keywords

Cerebellar granule cells; Organic solvents; Reactive oxygen species

Indexed keywords

DICHLOROFLUORESCEIN; HYDROCARBON; OCTANOL; REACTIVE OXYGEN METABOLITE; SOLVENT; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL TISSUE; CELL CULTURE; CEREBELLUM; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GRANULE CELL; LIPOPHILICITY; LONG TERM EXPOSURE; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CEREBELLUM; HYDROCARBONS, AROMATIC; LIPID METABOLISM; MALE; RATS; REACTIVE OXYGEN SPECIES; SOLVENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036902579     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-813X(02)00010-4     Document Type: Conference Paper

References (61)

1. Arlien-Søborg P, Hansen L, Ladefoged O, Simonsen L. Report on a conference on organic solvents and the nervous system. Neurotoxicol Teratol 1992;14:81-2.
2. Axelson O, Hogstedt C, The health effects of solvents. In: Zenz C, Dickerson OB, Horvath EP, editors. Occupational Medicine. 3rd Ed. Mosby: St. Louis, 1994. p. 764-78.
3. Bernsen HJ, Verhagen WI, de Bijl MA, Heerschap A. Magnetic resonance studies on brain dysfunction induced by organic solvents. Acta Neurol Belg 1992;92:207-14.
4. Bjornaes S, Naalsund LU. Biochemical changes in different brain areas after toluene inhalation. Toxicology 1988;49:367-74.
5. Bondy SC, Lam HR, Østergaard G, Guo SX, Ladefoged O. Changes in markers of oxidative status in brain, liver and kidney of young and aged rats following exposure to aromatic white spirit. Arch Toxicol 1995;69:410-4.
6. Cranmer and Goldberg, editors. Human aspects of solvent neurobehavioral effects. Report of the workshop session on clinical and epidemiological topics. Neurotoxicology 1987;7:45-56
7. Crow JP. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide-biol Ch 1997;1:145-57.
8. Cruz SL, Balster RL, Woodward JJ. Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Br J Pharmacol 2000;131(7):1303-8.
9. Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 1998;286(1):334-40.
10. Dick RB. Neurobehavioral assessment of occupationally relevant solvents and chemicals in humans. In: Chang LW, Dyer RS, editors. Handbook of Neurotoxicology. New York: Marcel Dekker, 1995. p. 217-322.
11. Feldman RG, Ratner MH, Ptak T. Chronic toxic encephalopathy in a painter exposed to mixed solvents. Environ Health Persp 1999;107:417-22.
12. Fonnum F. Excitotoxicity in the brain. Arch Toxicol Suppl 1998;20:387-95.
13. Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol Scand 1983;67:319-29.
14. Franks NP, Lieb WR. Do general anaesthetics act by competitive binding to specific receptors. Nature 1984;310:599-601.
15. Franks NP, Lieb WR. Mechanisms of general anaesthesia. Environ Health Persp 1990;87:199-205.
16. Gallo V, Ciotti MT, Coletti A, Aloisi F, Levi G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci USA 1982;79:7919-23.
17. Gunasekar PG, Kanthasamy AG, Borowitz JL, Isom GE. Monitoring intracellular nitric oxide formation by dichlorofluorescin in neuronal cells. J Neurosci Meth 1995;61:15-21.
18. Hageman G, van der Hoek J, van Hout M, van der Laan G, Steur EJ, de Bruin W, Herholz K. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol 1999;246:198-206.
19. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd Ed. New York: Oxford University Press, 1999. p. 246-350.
20. Hansch C, Leo A, Hoekman D. Hydrophobic, electronic, and steric constants. In: Heller SJ, editor. Exploring QSAR, vol. 2. Washington, DC: American Chemical Society, 1995. p. 3-216.
21. Halsey MJ. Molecular interactions of anaesthetics with biological membranes. Gen Pharmacol 1992;23:1013-6.
22. Holme J, Malvik B, Leira HL. Løsemiddeleksponering i Norge på 1980 og 1990 Tallet Fordelt på Bransjer og Arbeidsoperasjoner. Rapport/Arbeidsmedisinsk avdeling, Regionsykehuset i Trondheim; nr 03.2001. Trondheim, Arbeidsmedisinsk avdeling, Regionsykehuset i Trondheim, 2000. p. 1-22.
23. Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986;36:698-702.
24. Juntunen J. Neurotoxic syndromes and occupational exposure to solvents. Environ Res 1993;60:98-111.
25. Kamran S, Bakshi R. MRI in chronic toluene abuse: Low signal in the cerebral cortex on T2-weighted images. Neuroradiology 1998;40:519-21.
26. Khan S, Krishnamurthy R, Pandya KP. Generation of hydroxyl radicals during benzene toxicity. Biochem Pharmacol 1990;39:1393-5.
27. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Meth 1987;20:83-90.
28. Korbo L, Ladefoged O, Lam HR, Østergaard G, West MJ, Arlien-Søborg P. Neuronal loss in hippocampus in rats exposed to toluene. Neurotoxicology 1996;17:359-66.
29. Kukull WA, Larson EB, Bowen JD, McCormick WC, Teri L, Pfanschmidt ML, Thompson JD, O'Meara ES, Brenner DE, van Belle G. Solvent exposure as a risk factor for Alzheimer's disease: A case-control study. Am J Epidemiol 1995;141:1059-71.
30. Lam HR, Østergaard G, Guo SX, Ladefoged O, Bondy SC. Three weeks exposure of rats to dearomatized white spirit modifies indices of oxidative stress in brain, kidney, and liver. Biochem Pharmacol 1994;47:651-7.
31. Lam HR, Østergaard G, Ladefoged O. Three weeks and six months exposure to aromatic white spirit affect synaptosomal neurochemistry in rats. Toxicol Lett 1995;80:39-48.
32. Lam HR, Ladefoged O, Østergaard G, O'Callaghan JP. Inhalation exposure to white spirit causes region-dependent alterations in the levels of glial fibrillary acidic protein. Neurotoxicol Teratol 2000;22:725-31.
33. Landtblom AM, Flodin U, Soderfeldt B, Wolfson C, Axelson O. Organic solvents and multiple sclerosis: A synthesis of the current evidence. Epidemiology 1996;7:429-33.
34. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5:227-31.
35. Leira HL, Myhr G, Nilsen G, Dale LG. Cerebral magnetic resonance imaging and cerebral computerized tomography for patients with solvent-induced encephalopathy. Scand J Work Environ Health 1992;18:68-70.
36. Lund SP, Simonsen L, Hass U, Ladefoged O, Lam HR, Østergaard G. Dearomatized white spirit inhalation exposure causes long-lasting neurophysiological changes in rats. Neurotoxicol Teratol 1996;18:67-76.
37. Malm G, Lying-Tunell U. Cerebellar dysfunction related to toluene sniffing. Acta Neurol Scand 1980;62:188-90.
38. Mattia CJ, Adams Jr, JD, Bondy SC. Free radical induction in the brain and liver by products of toluene catabolism. Biochem Pharmacol 1993a;46:103-10.
39. Mattia CJ, Ali SF, Bondy SC. Toluene-induced oxidative stress in several brain regions and other organs. Mol Chem Neuropathol 1993;18:313-28.
40. Mattia CJ, LeBel CP, Bondy SC. Effects of toluene and its metabolites on cerebral reactive oxygen species generation. Biochem Pharmacol 1991;42:879-82.
41. McKarns SC, Hansch C, Caldwell WS, Morgan WT, Moore SK, Doolittle DJ. Correlation between hydrophobicity of shortchain aliphatic alcohols and their ability to alter plasma membrane integrity. Fundam Appl Toxicol 1997;36:62-70.
42. Morata TC, Fiorini AC, Fischer FM, Colacioppo S, Wallingford KM, Krieg EF, Dunn DE, Gozzoli L, Padrao MA, Cesar CL. Toluene-induced hearing loss among rotogravure printing workers. Scand J Work Environ Health 1997;23:289-98.
43. Myhre O, Fonnum F. The effect of aliphatic, naphthenic, and aromatic hydrocarbons on production of reactive oxygen species and reactive nitrogen species in rat brain synaptosome fraction: The involvement of calcium, nitric oxide synthase, mitochondria, and phospholipase A. Biochem Pharmacol 2001;62:119-28.
44. Myhre O, Sterri S, Bjugan B, Fonnum F. Activation of the ERK/MAPkinase Pathway by Nitric Oxide in Cultured Rat Cerebellar Granule Cells After Exposure to the Solvent 1,2,4-Trimethylcyclohexane. 2002, in preparation.
45. Myhre O, Vestad TA, Sagstuen E, Aarnes H, Fonnum F. Effects of the solvent 1,2,4-trimethylcyclohexane on respiratory burst in human neutrophil granulocytes. A chemiluminescence and electron paramagnetic resonance spectrometry study. Ann New York Acad Sci 1999;893:358-61.
46. Myhre O, Vestad TA, Sagstuen E, Aarnes H, Fonnum F. The effects of aliphatic (n-nonane), naphtenic (1,2, 4-trimethylcyclohexane), and aromatic (1,2,4-trimethylbenzene) hydrocarbons on respiratory burst in human neutrophil granulocytes. Toxicol Appl Pharmacol 2000;167:222-30.
47. Niklasson M, Arlinger S, Ledin T, Moller C, Odkvist L, Flodin U, Tham R. Audiological disturbances caused by long-term exposure to industrial solvents. Relation to the diagnosis of toxic encephalopathy. Scand Audiol 1998;27:131-6.
48. Nilsen OG, Haugen OA, Zahlsen K, Halgunset J, Helseth A, Aarset H, Eide I. Toxicity of n-C9-13 alkanes in the rat on short term inhalation. Pharmacol Toxicol 1988;62:259-66.
49. Possel H, Noack H, Augustin W, Keilhoff G, Wolf G. 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Lett 1997;416:175-8.
50. Pryor GT. A toluene-induced motor syndrome in rats resembling that seen in some human solvent abusers. Neurotoxicol Teratol 1991;13:387-400.
51. Ritter S, Hauthal WH, Maurer G. Octanol/water partition coefficients for environmentally important organic compounds. Environ Sci Pollut Res 1995;2:153-60.
52. Saavedra H, De Marinis A, Palestini M. Neuronal changes induced by chronic toluene exposure in the cat. Arch Ital Biol 1996;134:217-25.
53. Semple S, Dick F, Osborne A, Cherrie JW, Soutar A, Seaton A, Haites N. Impairment of colour vision in workers exposed to organic solvents. Occup Environ Med 2000;57:582-7.
54. Smargiassi A, Mutti A, De Rosa A, De Palma G, Negrotti A, Calzetti S. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 1998;19:709-12.
55. Thompson SA, Wafford K. Mechanism of action of general anaesthetics - New information from molecular pharmacology. Curr Opin Pharmacol 2001;1:78-83.
56. Vanacore N, Gasparini M, Brusa L, Meco G. A possible association between exposure to n-hexane and parkinsonism. Neurol Sci 2000;21:49-52.
57. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Rad Biol Med 1999;27:612-6.
58. Yamanouchi N, Okada S, Kodama K, Hirai S, Sekine H, Murakami A, Komatsu N, Sakamoto T, Sato T. White matter changes caused by chronic solvent abuse. Am J Neuroradiol 1995;16:1643-9.
59. Zavalic M, Mandic Z, Turk R, Bogadi-Sare A, Plavec D, Gomzi M, Skender LJ. Assessment of colour vision impairment in male workers exposed to toluene generally above occupational exposure limits. Occup Med (London) 1998;48:175-80.
60. Zahlsen K, Eide I, Nilsen AM, Nilsen OG. Inhalation kinetics of C6-10 aliphatic, aromatic and naphthenic hydrocarbons in rat after repeated exposures. Pharmacol Toxicol 1992;71:144-9.
61. Zahlsen K, Nilsen AM, Eide I, Nilsen OG. Accumulation and distribution of aliphatic (n-nonane), aromatic (1,2,4-trimethylbenzene) and naphthenic (1,2,4-trimethylcyclohexane) hydrocarbons in the rat after repeated inhalation. Pharmacol Toxicol 1990;67:436-40.